Mediclinic International Share Forecast, Price & News

GBX 316.80
-2.20 (-0.69 %)
(As of 04/19/2021 12:07 PM ET)
Today's Range
Now: GBX 316.80
50-Day Range
MA: GBX 296.83
52-Week Range
Now: GBX 316.80
Volume105,085 shs
Average Volume486,135 shs
Market Capitalization£2.34 billion
P/E RatioN/A
Dividend Yield3.12%
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 hospitals, 2 day case clinics, 3 outpatient clinics, and 110 theatres with approximately 1,893 inpatient beds in Switzerland; 52 hospitals, 10 day case clinics, 8 sub-acute hospitals, and 305 theatres in South Africa and Namibia with approximately 8,792 inpatient beds; and 7 hospitals, 2 day case clinics, 18 outpatient clinics, and 38 theatres with approximately 927 inpatient beds in the United Arab Emirates. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.
Mediclinic International logo

Industry, Sector and Symbol

Industry Medical Care
Year FoundedN/A



Sales & Book Value

Annual Sales£2.98 billion
Cash FlowGBX 35.56 per share
Book ValueGBX 393.60 per share



Market Cap£2.34 billion
Next Earnings Date5/26/2021 (Estimated)


Mediclinic International (LON:MDC) Trading 2.6% Higher
April 16, 2021 |  americanbankingnews.com
Mediclinic International (LON:MDC) Shares Down 1.2%
March 26, 2021 |  americanbankingnews.com
Why Mediclinic International's (LON:MDC) CEO Pay Matters
December 21, 2020 |  finance.yahoo.com
UPDATE 1-UK Stocks-Factors to watch on Nov 12
November 13, 2020 |  uk.reuters.com
Mediclinic International PLC
October 6, 2020 |  bloomberg.com
See More Headlines


Overall MarketRank

0.92 out of 5 stars

Analyst Opinion: 1.1Community Rank: 2.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
GBX 316.80
-2.20 (-0.69 %)
(As of 04/19/2021 12:07 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for MDC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Mediclinic International (LON:MDC) Frequently Asked Questions

Is Mediclinic International a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Mediclinic International stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View analyst ratings for Mediclinic International
or view top-rated stocks.

What stocks does MarketBeat like better than Mediclinic International?

Wall Street analysts have given Mediclinic International a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Mediclinic International wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Mediclinic International's next earnings date?

Mediclinic International is scheduled to release its next quarterly earnings announcement on Wednesday, May 26th 2021.
View our earnings forecast for Mediclinic International

How has Mediclinic International's stock been impacted by COVID-19 (Coronavirus)?

Mediclinic International's stock was trading at GBX 335.70 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MDC stock has decreased by 5.6% and is now trading at GBX 316.80.
View which stocks have been most impacted by COVID-19

Is Mediclinic International a good dividend stock?

Mediclinic International pays an annual dividend of GBX 0.03 per share and currently has a dividend yield of 3.12%.
View Mediclinic International's dividend history.

What price target have analysts set for MDC?

4 equities research analysts have issued 1-year target prices for Mediclinic International's shares. Their forecasts range from GBX 260 to GBX 323. On average, they anticipate Mediclinic International's stock price to reach GBX 301 in the next twelve months. This suggests that the stock has a possible downside of 5.0%.
View analysts' price targets for Mediclinic International
or view top-rated stocks among Wall Street analysts.

Who are Mediclinic International's key executives?

Mediclinic International's management team includes the following people:
  • Dr. Carel Aron van der Merwe, Group CEO & Exec. Director (Age 58, Pay $601k)
  • Mr. Petrus Jurgens Myburgh, Group CFO & Exec. Director (Age 46, Pay $442k)
  • Dr. Dirk C. Le Roux, Group Chief Information Officer (Age 61)
  • Mr. James Arnold, Head of Investor Relations
  • Mr. Magnus U. Oetiker, Group Chief Strategy and HR Officer (Age 49)
  • Mr. Gert C. Hattingh, Group Chief Governance Officer (Age 56)
  • Mr. Biren Valodia, Chief Marketing Officer of Medi-Clinic Southern Africa
  • Ms. Clara Findlay, Chief Legal Officer of Medicalinic Southern Africa
  • Mr. Wimpie Aucamp, Chief Operating Officer of Medi-Clinic for Southern Africa
  • Greg Van Wyk, Chief HR Officer of Medicalinic Southern Africa

Who are some of Mediclinic International's key competitors?

What other stocks do shareholders of Mediclinic International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), Rdi Reit (RDI), British American Tobacco (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO).

What is Mediclinic International's stock symbol?

Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

How do I buy shares of Mediclinic International?

Shares of MDC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Mediclinic International's stock price today?

One share of MDC stock can currently be purchased for approximately GBX 316.80.

How much money does Mediclinic International make?

Mediclinic International has a market capitalization of £2.34 billion and generates £2.98 billion in revenue each year.

How many employees does Mediclinic International have?

Mediclinic International employs 32,291 workers across the globe.

What is Mediclinic International's official website?

The official website for Mediclinic International is www.mediclinic.com.

Where are Mediclinic International's headquarters?

Mediclinic International is headquartered at 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom.

How can I contact Mediclinic International?

Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The company can be reached via phone at +44-20-79549600.

This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.